New Speakers at Diagnostic Clinical Affairs and Regulatory Approvals Conference

CHICAGO - July 1, 2014 - PRLog -- The most popular meeting for clinical and regulatory diagnostics professionals is scheduled for October 27-29, offering an exclusive opportunity for peer-to-peer networking, idea sharing and insight to best practices within the industry.  The 5th Annual Clinical Affairs and Regulatory Approvals for Diagnostics Conference will be held in Arlington, Virginia and is hosted by Q1 Productions.

New topics focusing on the latest trends and issues from all corners of the diagnostic industry are on this year’s agenda, such as applying FDA draft guidance, preparing for clinical and regulatory hurdles in China and FDA regulatory considerations for next-generation sequencing.  An FDA reviewer’s workshop is new this year, which will provide attendees with an opportunity to foster a one-on-one dialogue directly with FDA reviewers.  Ann Quinn of Ortho Clinical Diagnostics, Leanne Kiviharju of Illumina and Tadd Lazarus of Qiagen are among the distinguished presenters who will be on hand to offer valuable information during sessions and panel discussions.

Based on feedback from industry professionals, new to this year’s conference is a full day specifically focused on companion diagnostics, with several panel discussions and case studies that will open the floor for in-depth analysis of the current state of the industry.  Companion diagnostics experts, including Bill Pignato of Novartis Companion Diagnostics and Brian Baker of Roche Tissue Diagnostics-Ventana Medical Systems, are among a dozen speakers scheduled to present on this specialized course.

For more information or to register for the 5th Annual Clinical Affairs and Regulatory Approvals for Diagnostics Conference, please visit www.q1productions.com/ivdclinreg or contact marketing@q1productions.com.  You can also follow us on Twitter @Q1productions.


About the Organizer
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.